表紙:医療用コールドチェーンロジスティクスのアジア太平洋市場:成長、動向、COVID-19の影響、予測(2022年~2027年)
市場調査レポート
商品コード
1072172

医療用コールドチェーンロジスティクスのアジア太平洋市場:成長、動向、COVID-19の影響、予測(2022年~2027年)

Asia-Pacific Healthcare Cold Chain Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 150 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.51円
医療用コールドチェーンロジスティクスのアジア太平洋市場:成長、動向、COVID-19の影響、予測(2022年~2027年)
出版日: 2022年04月28日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 150 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

アジア太平洋の医療用コールドチェーンロジスティクスの市場規模は、予測期間中に10%を超えるCAGRで成長すると予想されています。

同市場の成長を後押しする主な要因には、コールドチェーンを必要とするバイオ医薬品やワクチンの需要の増加、温度に敏感な医薬品を効率的に取り扱うための政府規制の厳格化、人口増加による医療ニーズに対応するための医薬品分野の発展などが挙げられます。

当レポートでは、アジア太平洋の医療用コールドチェーンロジスティクス市場を調査しており、市場の概要、市場の成長要因および抑制要因の分析、製品・サービス・エンドユーザー・国別の分析、競合情勢、および企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

  • 分析調査手法
  • 調査段階

第3章 エグゼクティブサマリー

第4章 市場の洞察

  • 現在の市場シナリオ
  • 技術動向
  • 業界のバリューチェーン分析
  • 政府の規制とイニシアチブ
  • 周囲/温度制御ストレージにスポットライト
  • 冷蔵倉庫で使用される冷媒と包装材料への洞察
  • COVID-19の市場への影響

第5章 市場力学

  • 促進要因
  • 抑制要因
  • 市場機会
  • ポーターのファイブフォース分析

第6章 市場セグメンテーション

  • 製品別
    • バイオ医薬品
    • ワクチン
    • 臨床試験試料
  • サービス別
    • 輸送
    • 保管
    • 包装
    • ラベリング
  • エンドユーザー別
    • 病院&クリニックおよび製薬
    • バイオ医薬品
    • バイオテクノロジー企業
  • 国別
    • 中国
    • 日本
    • インド
    • その他アジア太平洋

第7章 競合情勢

  • 企業プロファイル
    • Cardinal Health
    • FedEx Corporation
    • DHL
    • CEVA Logistics
    • Agility
    • Kuehne+Nagel
    • DB Schenker
    • Marken Ltd.
    • Cavalier Logistics
    • Envirotainer*

第8章 市場の将来

第9章 付録

  • 活動別のGDP分布:主要国
  • キャピタルフローへの洞察:主要国
  • 経済統計:運輸および貯蔵部門、および経済への貢献(主要国)
  • 貨物統計(モード、製品カテゴリなど)

第10章 免責事項

目次
Product Code: 72623

Asia-Pacific Healthcare Cold Chain Logistics Market is expected to grow at a CAGR of over 10% during the forecast period.

Healthcare cold chain logistics firms, which are involved in the storage, movement, and flow of goods, have been directly influenced by the COVID-19 pandemic. The COVID-19 pandemic impacted the supply chain of the healthcare cold chain industry due to restricted trade during the pandemic, resulting in cold chain manufacturers emphasizing their storage to increase their shelf-life, which is likely to propel the growth of the market for cold chain. With rising disposable incomes and an aging population, the healthcare expenditure in the region is exhibiting strong growth rates and remains integral to the growth prospects of multinational pharmaceutical and biotechnology companies.

A number of Asia Pacific destinations such as India, China, Singapore, and South Korea, etc. are also emerging as major destinations for outsourcing clinical trials, drug manufacturing, and pathology testing. This has resulted in a rising demand for temperature-sensitive healthcare products such as vaccines, biopharmaceuticals, clinical trial materials, etc. These trends have driven the demand for cold storage facilities in the Asia-Pacific region and bolstered further investments in ongoing infrastructure improvements. Governments in some of Asian countries are taking corrective measures to improve healthcare cold chain logistics services.

The growth of the healthcare cold chain logistics market is attributed to the increasing demand for biopharmaceuticals and vaccines that require cold chains and stricter government regulations for the efficient handling of temperature-sensitive pharma products. In addition, the flourishing pharmaceutical sector to serve the healthcare needs of the growing population is fueling the demand for healthcare cold chain logistics. Factors, such as lack of standardization pertaining to operating procedures, security, temperature, pest control, and high operational cost, restraining the market growth.

Key Market Trends

Growth in the Pharmaceutical Sector Driving the Market

Pharmaceutical manufacturers in the Asia Pacific region are increasingly focusing on product quality and sensitivity. Factors, such as the development of complex biological-based medicines and shipment of hormone treatments, vaccines, & complex proteins that require cold chain refinements, result in the need for temperature-controlled transportation and warehousing.

Temperature-controlled logistics of pharmaceutical products and medical devices is a significantly growing part of the healthcare logistics industry. In the COVID-19 health crisis, cold chain logistics is playing a vital role for the pharmaceutical sector while increasing concern toward health is expected to support the growth of the Asia-Pacific healthcare cold chain logistics market.

During the first quarter of 2021, China led the top 50 Asia-Pacific (APAC) pharmaceutical firms in terms of market capitalization. At the end of Q1 2021, the aggregate market capitalization of the 50 APAC firms was up by 3.8% when compared to Q4 2020, with 28 Chinese companies accounting for 60% of the total market cap.

The Japanese pharmaceutical market is expanding to become the world's second-largest. Foreign direct investments (FDI) have steadily increased in the Japanese pharmaceutical sector over the years, assisting the country in establishing a global presence. Japan is home to four of the world's top 25 pharmaceutical companies.

An increase in the need for effective cold chain logistics services to maintain the quality of goods fueling the growth of the market. In addition, the entire cold chain and logistics for the pharmaceutical industry is becoming more strategic and reliable. High-value pharmaceutical products are mostly shipped via cold chain solutions across the entire distribution network, thereby driving the growth of the market in Asia-Pacific.

Increase in Number of Refrigerated Warehouses

The COVID-19 pandemic has resulted in a significant change in the supply chain outlook, enabling the growing usage of digital high-end technologies to attain operational efficiency along with health concerns. The changing logistics industry outlook, requirement for substantial cost optimization, and optimum inventory management are anticipated to support the growth of the Asia-Pacific healthcare cold chain logistics market.

Japanese logistics companies are putting their vast experience to work in Southeast Asia, building modern warehouses with features like temperature controls to meet the evolving requirements of local consumers. As people's incomes improve in Asia, they expect faster delivery of online shopping orders, necessitating automated warehouse handling to save time and rigorous temperature controls to keep goods fresh.

Thailand is the Asian country with the most advanced warehouses. Indonesia, with a population of over 270 million people, has enormous potential but has fallen behind in logistics development, owing in part to the transportation constraints posed by the country's numerous islands. However demand from domestic-market-focused enterprises is growing,

Businesses are investing millions of dollars in their cold chain operations to create effective, efficient, and reliable processes as end-to-end cold chain security is the weak link in the system. Moreover, the number of refrigerated warehouses is increasing, owing to a surge in demand for food and pharmaceuticals products in the Asia-Pacific region. Therefore, an increase in refrigerated warehouses is anticipated to boost the growth of the Asia-Pacific Healthcare Cold Chain Logistics Market.

Competitive Landscape

The Asia-Pacific healthcare cold chain logistics market is fragmented with rising competition, product launches, collaborative partnerships, and other strategic decisions that are undertaken to achieve operational efficiency. Some of the major players include DHL, CEVA Logistics, Cardinal Health, etc. The key players have adopted the strategy of signing contracts and agreements for expanded regional reach and optimized operational costs. The market is highly competitive, with players competing and partnering to gain a substantial market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

  • 2.1 Analysis Methodology
  • 2.2 Research Phases

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Current Market Scenario
  • 4.2 Technological Trends
  • 4.3 Industry Value Chain Analysis
  • 4.4 Government Regulations and Initiatives
  • 4.5 Spotlight on Ambient/Temperature-controlled Storage
  • 4.6 Insights into Refrigerants and Packaging Materials Used in Refrigerated Warehouses
  • 4.7 Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Drivers
  • 5.2 Restraints
  • 5.3 Opportunities
  • 5.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 5.4.1 Bargaining Power of Suppliers
    • 5.4.2 Bargaining Power of Consumers / Buyers
    • 5.4.3 Threat of New Entrants
    • 5.4.4 Threat of Substitute Products
    • 5.4.5 Intensity of Competitive Rivalry

6 MARKET SEGMENTATION

  • 6.1 By Product
    • 6.1.1 Biopharmaceuticals
    • 6.1.2 Vaccines
    • 6.1.3 Clinical Trial Materials
  • 6.2 By Services
    • 6.2.1 Transportation
    • 6.2.2 Storage
    • 6.2.3 Packaging
    • 6.2.4 Labelling
  • 6.3 By End User
    • 6.3.1 Hospital & Clinics and Pharmaceutical
    • 6.3.2 Biopharmaceutical
    • 6.3.3 Biotechnology Companies
  • 6.4 By Country
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Rest of Asia-Pacific

7 COMPETITIVE LANDSCAPE

  • 7.1 Overview (Market Concentration and Major Players)
  • 7.2 Company Profiles
    • 7.2.1 Cardinal Health
    • 7.2.2 FedEx Corporation
    • 7.2.3 DHL
    • 7.2.4 CEVA Logistics
    • 7.2.5 Agility
    • 7.2.6 Kuehne + Nagel
    • 7.2.7 DB Schenker
    • 7.2.8 Marken Ltd.
    • 7.2.9 Cavalier Logistics
    • 7.2.10 Envirotainer*

8 FUTURE OF THE MARKET

9 APPENDIX

  • 9.1 GDP Distribution, by Activity - Key Countries
  • 9.2 Insights into Capital Flows - Key Countries
  • 9.3 Economic Statistics - Transport and Storage Sector, and Contribution to Economy (Key Countries)
  • 9.4 Freight Statistics (Mode, Product Category, etc.)

10 DISCLAIMER